Biotechnology, one of molecular biology’s branches, monitored and intentional manipulation of biological organisms, processes or systems to effectively make or process drugs, or any other products and substances useful to enhancing people’s living quality. The earliest examples of humans applying their knowledge of biotechnology involved the efforts to enhance plants and animals’ species by cross-pollination (allogamy) or cross-breeding.
Biotechnology has recently turned to a more sophisticated business, considerably enlarged in scale and application range. Having goodly restored from the recession, the world Biotechnology Market is anticipated to be eventually estimated at far over EUR 245 billion by end-2015. However, with the numerous benefits this advanced technology comes laden with, there are worries about its potential misuse. Concerns over this issue has trailed into some attempting to facilitate the enforcement of specific laws constraining or even banning relevant programs and research (e.g. human cloning).
The research reports from this Catalogue offer a comprehensive outlook on the worldwide Biotechnology Market. The reports identify major market challenging forces and growth drivers, provide fresh statistics on the Biotechnology Industry, outline various trends and factors specifying the market’s direction, and more. Regional and country markets’ reviews are at hand in the reports too. Furthermore, companies with their innovations are discussed, and also short to long term forecasts are provided in the researches.
Publications found:
1,310
Sort by:
Overview of Bacillus Cereus in China
US$ 1,126.00
... and many raw and processed foods. Overview of Bacillus Cereus in China is CCM International's first edition report on Chinese bacillus cereus industry, finished in April 2011. This intelligent ...
April 2011
14 pages
Overview of Bacillus Subtilis in China
US$ 1,126.00
... which 5 are for technical, 17 for formulations. Overview of Bacillus subtilis in China is CCM International's first edition report on Chinese bacillus subtilis industry, finished in April 2011. This intelligent ...
April 2011
15 pages
US Stem Cell Market Analysis
US$ 800.00
Single User PDF Format: US$ 800.00
Multi-User License: US$ 1,400.00
Hard Copy: US$ 1,000.00
CD-ROM: US$ 900.00 The stem cell market has been growing at a fast pace for the past few yea...
April 2011
65 pages
UK Generics Market Analysis
US$ 800.00
Single User PDF Format: US$ 800.00 Multi-User License: US$ 1,100.00 Hard Copy: US$ 900.00 CD-ROM: US$ 900.00 The UK is one of the largest economies in the world. The per capita income and spending ha...
April 2011
55 pages
Biosimilars Update
US$ 695.00
From Canada and the US to Japan, the EU and Australia, regulators around the world are establishing guidelines that will pave the way for competition between biosimilars and costly biologics. For many...
April 2011
140 pages
Japanese Generic Market Forecast to 2013
US$ 800.00
Single User PDF Format: US$ 800.00
Multi-User License: US$ 1,400.00
Hard Copy: US$ 900.00
CD-ROM: US$ 900.00 Generic drugs are produced and distributed without patent protection and ma...
March 2011
45 pages
Asia Pacific Markets for Dental Bone Graft Substitutes and Other Biomaterials 2011
US$ 8,495.00
... grew by 3.7% over 2009 and were valued at $69 million. The Asia-Pacific markets for dental bone graft substitutes and Other Biomaterials covers ... market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios. The executive summary of this report ...
March 2011
221 pages
Bioinformatics - A Global Market Overview
US$ 4,320.00
At the beginning of the “genomic revolution”, Bioinformatics was applied in creating and maintaining a database that stored biological information, such as nucleotide and amino acid sequences. Development of this type of database involved not...
March 2011
264 pages
Emerging Biotech Sector in Malaysia
US$ 1,100.00
Single User PDF Format: US$ 1,100.00
Multi-User License: US$ 1,800.00
Hard Copy: US$ 1,300.00
CD-ROM: US$ 1,300.00 Malaysia has effectively witnessed an upsurge in the profitability an...
February 2011
90 pages
Biosimilars Regulatory Update: an Evolving Landscape
US$ 395.00
They’re costly to develop, fraught with potential patient safety concerns and subject to regulations that have yet to be written. Yet for the pharmaceutical industry, biosimilar monoclonal antibodies...
February 2011
59 pages
Stem Cells Research: Market Research Report
US$ 4,500.00
This report analyzes the US Market for Stem Cells Research in US$ Million. Annual forecasts are provided for the period 2006 through 2015. The ... , Inc., Osiris Therapeutics, StemCells, Inc., ThermoGenesis Corp., and ViaCord, LLC. Market data and analytics are derived from primary and secondary research. ...
February 2011
566 pages
Brazil Generics Market Forecast to 2012
US$ 1,000.00
Single User PDF Format: US$ 1,000.00
Multi-User License: US$ 1,400.00
Hard Copy: US$ 1,100.00
CD-ROM: US$ 1,100.00 Since the initial launch of policies, Brazil generic drugs market has...
January 2011
60 pages
Adult Stem Cells Market Trends 2011
US$ 1,986.00
... analyzes the umbilical cord blood marketplace from a technical as well as market perspective describing the types of transplantation utilizing cord blood, disease ... into stem cell research trends (both qualitative and quantitative). This data-driven characterization of the adult stem cells market landscape ...
December 2010
100 pages
Stem Cell Market: Opportunities and Challenges
US$ 800.00
... previously been no effective treatment. The medical stem cells market is divided into three categories: stem cell therapeutics, cord blood banking and drug ... projected to be the second largest and second fastest growing market. US is the major stem cell market in the world and has recently been boosted by ...
December 2010
44 pages
Competitor Analysis Antibody Therapy of Inflammatory and Autoimmune Diseases
US$ 1,184.00
Product description The present Competitive Intelligence Report about Antibody Therapy of Inflammatory and Autoimmune Diseases provides a competitor evaluation in the field of antibody therapeutics used or being developed for treatment of rheumatoid arthritis, psoriasis, Crohn’s disease, ulcerative colitis ...
December 2010
172 pages
Global Monoclonal Antibody Market Analysis
US$ 1,200.00
Single User PDF Format: US$ 1,200.00
Multi-User License: US$ 1,600.00
Hard Copy: US$ 1,300.00
CD-ROM: US$ 1,300.00 Considered as an indispensable tool in the clinical and biotechnology...
November 2010
80 pages
Generic Substitution: Taking a Narrow View?
US$ 395.00
As health care expenditures rise, governments, payers, healthcare providers and patients alike are focused intently on one thing: capping runaway costs. For the generics industry, it heralds a boom-ti...
November 2010
54 pages
Antibody Pipeline Database: 1-Year Subscription
US$ 1,638.00
... numerical order, e.g. for phase, product category or company name. Sample screenshots illustrate the database. Purchase of the subscription provides a 1-year online access to the data of the Antibody Pipeline Database. Credentials to access the database will be sent by e-mail within 24 hours after purchase. ...
November 2010
Biosimilars: Surveying the Market Landscape
US$ 395.00
Worldwide, the story is the same. Governments want cheaper drugs for their populations, while the number and kinds of diseases affecting them continue to evolve and grow. Since 1976, when Genentech be...
October 2010
75 pages
Human Embryonic Stem Cells (hESC) - A Global Market Overview
US$ 4,680.00
Embryonic stem cell (hESC) research has attracted a lot of attention the world over and the controversy surrounding it just does not seem to die down. Stem cells are unspecialized cells that are capable of differentiating into any other cell type....
July 2010
216 pages
Specialty Generics: Climbing the Value Chain
US$ 195.00
“Mighty things from small beginnings grow,” John Dryden once astutely noted. Although the influential 17th century poet and literary critic knew nothing of medicine and marketing, his words ring true...
June 2010
34 pages
Branded Generics: A Gateway to Emerging Markets
US$ 295.00
Around the globe, emerging markets are on the move. From Brazil, Russia and India to China, Turkey, Mexico and South Korea, experts predict emerging markets will represent 70 percent of industry growt...
June 2010
46 pages
Stem Cells - The Hype and the Hope 2010-2025
US$ 2,325.00
... cord injury, blindness, immune system disorders and cardiovascular disease. Stem Cells - The Hype and the Hope 2010-2025 provides an analytical ... benefits in particular: You will receive a comprehensive analysis of the prospects for stem cells from 2010 to 2025, including predicted revenues, growth rates ...
May 2010
201 pages
Future of Red Biotechnology in China
US$ 14,897.00
... mode in China? What is covered in this report? Overview of China’s red biotechnology; Detailed analysis of each sub-categories of red biotechnologies in China: gene ... R&D, production, technology advancement and future trends in China’s red biotechnology; Keep informed of the precise development situation of ...
April 2010
178 pages
Biosimilars: Market Research Report
US$ 3,950.00
This report analyzes the worldwide markets for Biosimilars in US$ Million. The report provides separate comprehensive analytics for US, Europe, and Japan. ... , Shantha Biotechnics Ltd., Teva Pharmaceutical Industries Ltd., and Wockhardt Ltd. Market data and analytics are derived from primary and secondary ...
April 2010
390 pages
Nanobiotechnology: Market Research Report
US$ 4,450.00
This report analyzes the worldwide markets for Nanobiotechnology in US$ Million by the following technology segments: Nanomaterials (Solid Inorganic Nanoparticles, Nanocomposites, Nanostructured Materials & Membranes, Nanotubes and Fullerenes, & Other Nanomaterials), and Nanodevices/Tools. The report ...
February 2010
827 pages
Asia Pacific Market for Bone Graft Substitutes and Other Biomaterials 2009 (3 Countries)
US$ 8,495.00
... includes Japan, South Korea, and Australia. In 2008, the combined Asia-Pacific market for dental bone graft substitutes (BGS) and other biomaterials was ... account for an unusually large percentage of dental BGS materials used in the Asia-Pacific region because allograft and xenograft products are not approved ...
November 2009
200 pages
Global Stem Cell and Advanced Technologies Market
US$ 5,650.00
... the global stem cell market as follows: • Stem Cell Products (adult stem cell, human embryonic stem cell, and other stem cell types) • Stem Cell Services (stem cell banking, stem cell ... and Power Supplies, Food and Beverages, Chemicals, Advanced Materials, Industrial Automation, and Telecom and IT. We ...
November 2009
229 pages
Future of Green Biotechnology in China
US$ 9,683.00
... mentioned above are summarized specifically. - Overview of China’s green biotechnology: A higher level analysis and summary - Future ... in market, R&D and applications of China’s green biotechnology - Discover the potential opportunities for green biotechnology in China - Benefit from a thorough review of ...
October 2009
131 pages
European Markets for Dental Bone Graft Substitutes and Other Biomaterials 2009
US$ 11,495.00
In 2008, the combined European market for dental bone graft substitutes and other biomaterials increased by 12.9% over 2007. The European market includes Austria, Benelux, France, Germany, Israel, Italy, Poland, Portugal, Scandinavia, Spain, Switzerland and ...
September 2009
545 pages
Austrian Market for Dental Bone Graft Substitutes and Other Biomaterials 2009
US$ 4,495.00
In 2008, the Austrian market for dental bone graft substitutes grew by double digit rates. The 2008 average selling price was similar to the European average and can be expected to increase over the forecast period. Future growth will be driven by an increasing number of implant ...
September 2009
70 pages
Beneluxian Market for Dental Bone Graft Substitutes and Other Biomaterials 2009
US$ 4,495.00
The Beneluxian market for dental bone graft substitutes and other biomaterials, which includes Belgium, the Netherlands and Luxemburg, was the seventh largest in Europe in 2008. The Netherlands represented the vast majority of this market, which grew significantly in 2007. The rapid growth in the number of ...
September 2009
70 pages
French Market for Dental Bone Graft Substitutes and Other Biomaterials 2009
US$ 4,495.00
In 2008, the French market for dental bone graft substitutes was the fourth largest in Europe. The 2008 average selling price for dental ... higher material costs and a lack of government and private insurance coverage. The French market will continue to see double digit growth driven by an increasing number of ...
September 2009
70 pages
Polish Market for Dental Bone Graft Substitutes and Other Biomaterials 2009
US$ 4,495.00
The Polish market for dental bone graft substitutes and other biomaterials was the ninth largest in Europe. In 2008, growth in the number of ... implant procedures well into double digit rates over the forecast period. Poland is also associated with greater use of mineralized allografts, bolstered by demand for ...
September 2009
70 pages
Swiss Market for Dental Bone Graft Substitutes and Other Biomaterials 2009
US$ 4,495.00
In 2008, the Swiss market for dental bone graft substitutes and other biomaterials grew at double digit rates. While Switzerland has a relatively small population, it has one of the highest dental implant per capita rates in Europe, driving bone graft substitute use. ...
September 2009
70 pages
U.K. Market for Dental Bone Graft Substitutes and Other Biomaterials 2009
US$ 4,495.00
The U.K. market for dental bone graft substitutes and other biomaterials was the sixth largest in Europe in 2008. The market growth rate is predicted to be well above the European average over the forecast period. Average selling prices for dental bone ...
September 2009
70 pages
Global Biomaterial Market (2009-2014)
US$ 5,650.00
... global biomaterial market as follows: Biomaterials product market Orthopaedic, cardiovascular, gastrointestinal, wound care, plastic surgery, urological and others Biomaterials ingredient market Metals, polymers, ceramics, composites Biomaterials application market ...
September 2009
256 pages
Biosimilars (2009 - 2014)
US$ 5,650.00
... numerous opportunities in the global biosimilars market. The global biosimilars market is expected to be worth US$19.4 billion by 2014, growing at a CAGR of 89.1% from 2009 to 2014. The biosimilars market is segmented into ... of the global biosimilars market. The American market is expected to dominate in 2014 after the U.S. market opens up in 2010. Currently, the global biosimilars market is highly ...
September 2009
189 pages
